Showing results (31-40 of 41) with videos related to
Sort By:
Pageof 5
Cancer|June 23, 2025
Mitochondrial proteome landscape unveils key insights into melanoma severity and treatment strategiesYonghyo Kim, Viktória Doma, Uğur Çakır, et al.Clinical and Translational Medicine|September 29, 2025
Distant metastases of melanoma exhibit varying extent of intrapatient proteogenomic heterogeneityBeata Szeitz, Yanick Paco Hagemeijer, Zoltan Gabor Pahi, et al.Journal of Proteomics|April 17, 2025
Comprehensive biobanking strategy with clinical impact at the European Cancer Moonshot Lund CenterHenriett Oskolas, Fábio C N Nogueira, Gilberto B Domont, et al.Biorxiv : the Preprint Server for Biology|March 28, 2024
Identifying Ferroptosis Inducers, HDAC, and RTK Inhibitor Sensitivity in Melanoma Subtypes through Unbiased Drug Target PredictionIndira Pla, Botond L Szabolcs, Petra Nikolett Péter, et al.Journal of Proteome Research|May 5, 2025
Melanoma Proteomics Unveiled: Harmonizing Diverse Data Sets for Biomarker Discovery and Clinical Insights via MEL-PLOTÁron Bartha, Boglárka Weltz, Lazaro Hiram Betancourt, et al.Cell Biology and Toxicology|March 23, 2019
Clinical protein science in translational medicine targeting malignant melanomaJeovanis Gil, Lazaro Hiram Betancourt, Indira Pla, et al.Biorxiv : the Preprint Server for Biology|May 15, 2024
Predicting immune checkpoint therapy response in three independent metastatic melanoma cohortsLeticia Szadai, Aron Bartha, Indira Pla Parada, et al.International Journal of Dermatology|December 25, 2024
Unbiased Drug Target Prediction Reveals Sensitivity to Ferroptosis Inducers, HDAC and RTK Inhibitors in Melanoma SubtypesIndira Pla, Botond L Szabolcs, Petra Nikolett Péter, et al.Frontiers in Oncology|July 17, 2024
Predicting immune checkpoint therapy response in three independent metastatic melanoma cohortsLeticia Szadai, Aron Bartha, Indira Pla Parada, et al.Clinical and Translational Medicine|July 29, 2021
The Human Melanoma Proteome Atlas-Complementing the melanoma transcriptomeLazaro Hiram Betancourt, Jeovanis Gil, Aniel Sanchez, et al.Pageof 5